ClearPoint Neuro (CLPT) Competitors

ClearPoint Neuro (NASDAQ:CLPT) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, community ranking, analyst recommendations, earnings and valuation.

Do analysts recommend CLPT or PDEX?

ClearPoint Neuro currently has a consensus price target of $11.33, suggesting a potential upside of 0.83%. Pro-Dex has a consensus price target of $52.00, suggesting a potential upside of 8.76%. Given Pro-Dex's higher possible upside, analysts clearly believe Pro-Dex is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Pro-Dex	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has preferable valuation and earnings, CLPT or PDEX?

Pro-Dex has higher revenue and earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$23.95M	12.94	-$22.09M	-$0.69	-16.29
Pro-Dex	$56.80M	2.74	$2.13M	$1.54	31.05

Is CLPT or PDEX more profitable?

Pro-Dex has a net margin of 9.17% compared to ClearPoint Neuro's net margin of -59.64%. Pro-Dex's return on equity of 16.74% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-59.64%	-62.10%	-38.39%
Pro-Dex	9.17%	16.74%	9.98%

Do institutionals & insiders have more ownership in CLPT or PDEX?

30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 6.1% of ClearPoint Neuro shares are held by insiders. Comparatively, 47.5% of Pro-Dex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community favor CLPT or PDEX?

Pro-Dex received 130 more outperform votes than ClearPoint Neuro when rated by MarketBeat users. However, 88.00% of users gave ClearPoint Neuro an outperform vote while only 61.54% of users gave Pro-Dex an outperform vote.

Company	Underperform	Outperform
ClearPoint Neuro	Outperform Votes 22 88.00%	Underperform Votes 3 12.00%
Pro-Dex	Outperform Votes 152 61.54%	Underperform Votes 95 38.46%

Does the media prefer CLPT or PDEX?

In the previous week, ClearPoint Neuro had 6 more articles in the media than Pro-Dex. MarketBeat recorded 14 mentions for ClearPoint Neuro and 8 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.82 beat ClearPoint Neuro's score of 0.39 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ClearPoint Neuro	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pro-Dex	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, CLPT or PDEX?

ClearPoint Neuro has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500.

Summary

Pro-Dex beats ClearPoint Neuro on 11 of the 17 factors compared between the two stocks.